Huntington's Disease News and Research

Latest Huntington's Disease News and Research

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

Stem cell lines are ideal research tools for designing models to understand disease progression

Stem cell lines are ideal research tools for designing models to understand disease progression

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Researchers identify likely molecular pathway that causes untreatable neurodegenerative diseases

Researchers identify likely molecular pathway that causes untreatable neurodegenerative diseases

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros announces positive data from OMS824 Phase 1 clinical trial

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Adhering to MedDi does not appear associated with time to clinical onset of HD

Adhering to MedDi does not appear associated with time to clinical onset of HD

Blood test provides tool essential to trials of therapies for Huntington's disease

Blood test provides tool essential to trials of therapies for Huntington's disease

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

ASO may correct striatal transcriptional abnormalities and improve behavioral problems in HD mice

ASO may correct striatal transcriptional abnormalities and improve behavioral problems in HD mice

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences signs definitive agreement to buy Ceregene

Glutathione peroxidase activity protects against symptoms of Huntington's disease

Glutathione peroxidase activity protects against symptoms of Huntington's disease

Psychogenics Picks Up Alzheimer’s Animal Model From USF

Psychogenics Picks Up Alzheimer’s Animal Model From USF

Research suggests Huntington's disease might begin in synapses

Research suggests Huntington's disease might begin in synapses

Omeros announces financial results for second quarter of 2013

Omeros announces financial results for second quarter of 2013

Study: 3 enzymes required for building sugar superstructure involved in muscular dystrophies

Study: 3 enzymes required for building sugar superstructure involved in muscular dystrophies

Researchers discover solution to long-standing medical mystery in Huntington's disease

Researchers discover solution to long-standing medical mystery in Huntington's disease

Discovery points to new therapeutic strategy for Parkinson's disease

Discovery points to new therapeutic strategy for Parkinson's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.